198 related articles for article (PubMed ID: 21854753)
21. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
22. Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.
Marech I; Ammendola M; Sacco R; Sammarco G; Zuccalà V; Zizzo N; Leporini C; Luposella M; Patruno R; Filippelli G; Russo E; Porcelli M; Gadaleta CD; De Sarro G; Ranieri G
J Cell Mol Med; 2016 Jul; 20(7):1373-80. PubMed ID: 27105577
[TBL] [Abstract][Full Text] [Related]
23. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
Suzuki S; Dobashi Y; Hatakeyama Y; Tajiri R; Fujimura T; Heldin CH; Ooi A
BMC Cancer; 2010 Nov; 10():659. PubMed ID: 21118571
[TBL] [Abstract][Full Text] [Related]
25. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
Ek ET; Ojaimi J; Kitagawa Y; Choong PF
Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
[TBL] [Abstract][Full Text] [Related]
26. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
27. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
[TBL] [Abstract][Full Text] [Related]
28. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
29. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.
Kono H; Fujii H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Tsuchiya M; Hosomura N; Sun C
World J Gastroenterol; 2016 Oct; 22(39):8779-8789. PubMed ID: 27818593
[TBL] [Abstract][Full Text] [Related]
30. Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury.
Javeshghani D; Barhoumi T; Idris-Khodja N; Paradis P; Schiffrin EL
Hypertension; 2013 Jul; 62(1):112-7. PubMed ID: 23670300
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma.
Guşet G; Costi S; Lazăr E; Dema A; Cornianu M; Vernic C; Păiuşan L
Rom J Morphol Embryol; 2010; 51(4):677-82. PubMed ID: 21103625
[TBL] [Abstract][Full Text] [Related]
32. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
33. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
34. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
36. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinomas in cirrhotic and noncirrhotic human livers share angiogenic characteristics.
Zeng W; Gouw AS; van den Heuvel MC; Molema G; Poppema S; van der Jagt EJ; de Jong KP
Ann Surg Oncol; 2010 Jun; 17(6):1564-71. PubMed ID: 20087783
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
